A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
- PMID: 35054049
- PMCID: PMC8780075
- DOI: 10.3390/jcm11020355
A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
Abstract
Chemotherapy induced peripheral neuropathy (CIPN) is a dose-limiting side effect of chemotherapy for which no prevention or cure exists. Cancer and cancer treatments can adversely affect nutritional status. Nutrition may play a role in development of CIPN, yet the relationship between nutrition and CIPN is not well understood. Common laboratory values measuring various aspects of nutrition (hemoglobin/hematocrit, vitamin B12, calcium, and magnesium) may be associated with CIPN. The aim of this systematic review is to evaluate the empirical evidence surrounding the relationship between laboratory measures of nutrition and CIPN among persons with cancer who received neurotoxic chemotherapy drugs. We conducted an extensive review of the literature to identify articles that evaluated relationships between laboratory measures of nutrition and CIPN. A total of eleven articles satisfied the inclusion/exclusion criteria. Participants in the studies had breast or colorectal cancer, lymphoma or multiple myeloma and were receiving a variety of neurotoxic drugs. Hemoglobin/hematocrit, vitamin D, albumin, and magnesium were associated with CIPN. The quality of the studies ranges from fair to good. Evidence suggests that low levels of the above-mentioned tests could be associated with CIPN but additional research is needed.
Keywords: CIPN; chemotherapy; chemotherapy induced peripheral neuropathy; laboratory; neuropathy; neurotoxicity; nutritional deficiency.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Loprinzi C.L., Lacchetti C., Bleeker J., Cavaletti G., Chauhan C., Hertz D.L., Kelley M.R., Lavino A., Lustberg M.B., Paice J.A., et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J. Clin. Oncol. 2020;38:3325–3348. doi: 10.1200/JCO.20.01399. - DOI - PubMed
-
- Hsu H.T., Wu L.M., Lin P.C., Juan C.H., Huang Y.Y., Chou P.L., Chen J.L. Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: A cross-sectional study. Medicine. 2020;99:e19029. doi: 10.1097/MD.0000000000019029. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Miscellaneous